Home > Financial Ratios > BAL PHARMA

BAL PHARMA
Price to Cash Earnings (PCE)

    Back to All Ratios
BAL PHARMA is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for BAL PHARMA
Please provide your vote to see the results

BAL PHARMA Last 5 Year Price to Cash Earnings (PCE) History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   PCE(x) 8.238.9410.845.60-8.85

What is the latest Price to Cash Earnings (PCE) ratio of BAL PHARMA ?

The latest Price to Cash Earnings (PCE) ratio of BAL PHARMA is 8.23 based on Mar2024 Consolidated results.
Year Price to Cash Earnings (PCE)
Mar20248.23
Mar20238.94
Mar202210.84
Mar20215.60
Mar2020-8.85

How is Price to Cash Earnings (PCE) of BAL PHARMA Trending?

Years Price to Cash Earnings (PCE) % Change
Mar2024 8.23
-7.94
Mar2023 8.94
-17.53
Mar2022 10.84
93.57
Mar2021 5.6
Positive
Mar2020 -8.85 -

Other Financial Ratios of BAL PHARMA


Compare Price to Cash Earnings (PCE) ratio of peers of BAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BAL PHARMA ₹163.9 Cr -7.8% 10.4% 4.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹433,032.0 Cr 0.9% 2.2% 23.9% Stock Analytics
DIVIS LABORATORIES ₹162,252.0 Cr 3.3% 4.7% 58% Stock Analytics
CIPLA ₹124,457.0 Cr 0.5% 2% 11.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹112,425.0 Cr -0.4% 2.8% 24.2% Stock Analytics
DR REDDYS LABORATORIES ₹98,152.8 Cr -0.8% -0.4% 0.8% Stock Analytics


BAL PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BAL PHARMA

-7.8%

10.4%

4.6%

SENSEX

0.9%

3%

8.9%


You may also like the below Video Courses